Spectrum Pharmaceuticals, Inc. (SPPI) Posts Mixed Q2 Results
Get Alerts SPPI Hot Sheet
Price: $1.03 --0%
EPS Growth %: +100.0%
Financial Fact:
Income (loss) before provision for income taxes: -17.92M
Today's EPS Names:
FSI, RELV, NEOM, More
EPS Growth %: +100.0%
Financial Fact:
Income (loss) before provision for income taxes: -17.92M
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q2 EPS of $0.12, $0.03 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $45.5 million versus the consensus estimate of $37.25 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
- Franklin Covey (FC) Tops Q2 EPS by 1c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!